Authors: RUDBACH JA KEEGAN DS SOWELL CG

Citation: Ja. Rudbach et al., CALCULATING THERAPEUTIC INDEXES AND THERAPEUTIC ADVANTAGES FOR ENDOTOXINS AND MONOPHOSPHORYL LIPID-A - AN EVALUATION OF DATA FROM THE SCIENTIFIC LITERATURE, Journal of endotoxin research, 2(4), 1995, pp. 301-310

Authors: ASTIZ ME RACKOW EC STILL JG HOWELL ST CATO A VONESCHEN KB ULRICH JT RUDBACH JA MCMAHON G VARGAS R STERN W

Citation: Me. Astiz et al., PRETREATMENT OF NORMAL HUMANS WITH MONOPHOSPHORYL LIPID-A INDUCES TOLERANCE TO ENDOTOXIN - A PROSPECTIVE, DOUBLE-BLIND, RANDOMIZED, CONTROLLED TRIAL, Critical care medicine, 23(1), 1995, pp. 9-17

Authors: CONLEY AJ CONARD P BONDY S DOLAN CA HANNAH J LEANZA WJ MARBURG S RIVETNA M RUSIECKI VK SUGG EE VANMIDDLESWORTH F WARNE SA ULRICH JT RUDBACH JA TOLMAN RL EMINI EA

Citation: Aj. Conley et al., IMMUNOGENICITY OF SYNTHETIC HIV-1 GP120 V3-LOOP PEPTIDE-CONJUGATE IMMUNOGENS, Vaccine, 12(5), 1994, pp. 445-451

Authors: DOMER JE HUMAN LG ANDERSEN GB RUDBACH JA ASHERSON GL

Citation: Je. Domer et al., ABROGATION OF SUPPRESSION OF DELAYED-HYPERSENSITIVITY INDUCED BY CANDIDA-ALBICANS-DERIVED MANNAN BY TREATMENT WITH MONOPHOSPHORYL LIPID-A, Infection and immunity, 61(5), 1993, pp. 2122-2130